Tandem Diabetes Care, Inc. Gain (Loss) on Termination of Lease
Tandem Diabetes Care, Inc. (TNDM) reported Gain (Loss) on Termination of Lease of -$3.80 million for the 3-month period ending 2022-12-31, per its 10-K filed 2024-02-21.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnTerminationOfLease · last filed 2024-02-21
- Tandem Diabetes Care, Inc. gain (loss) on termination of lease for the quarter ending 2022-12-31 was -$3.80M.
| Period end | Gain (Loss) on Termination of Lease 3 month |
|---|---|
| 2022-12-31 | -$3.80M 10-K · filed 2024-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |